Prevention of chemotherapy-induced neutropenia by special honey intake (original) (raw)

Abstract

Febrile neutropenia is a serious side effect of chemotherapy. Colony-stimulating factors (SCFs) are used for primary and secondary treatment in patients with grade 4 neutropenia. The use of CSFs is expensive and accompanied by side effects. In the current study, Life-Mel Honey (LMH) was administered to prevent neutropenia and to reduce the need for CSFs in patients treated with chemotherapy. Thirty cancer patients receiving chemotherapy for primary or metastatic disease were included. All patients had grade 4 neutropenia and were treated with CSFs. The patients repeated the same chemotherapy schedule, with the addition of LMH for 5 d. Blood count was performed weekly. There was no recurrence of neutropenia after LMH intake and no need for treatment with CSFs in 12 (40%) of patients. Eighteen (60%) patients with LMH developed neutropenia grade 4 and were treaeed with CSFs (_p_=0.007). Hemoglobin levels remained>11 g/dL during LMH intake in 19 (64%) patients. Only three (10%) patients had thrombocytopenia. Eight (32%) patients reported improvement in quality of life. The use of LMH in patients who are at high risk of developing neutropenia as a result of chemotherapy decreases the risk of pancytopenia and the need for CSFs. LMH is inexpensive, has no side effects, and is easy to administer.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ozer H. et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 2000;18: 3558–3585.
    PubMed CAS Google Scholar
  2. Blay JY, et al. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol 1996;14:636–643.
    PubMed CAS Google Scholar
  3. Infectious Disease Society of America. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–751.
    Article Google Scholar
  4. Phillips K, Tannock IF. Design and interpretation of clinical trails that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. J Clin Oncol 1998;16: 3179–3190.
    PubMed CAS Google Scholar
  5. Bokemeyer C, et al. Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy. Ann Hematol 1996; 72:1–9.
    PubMed CAS Google Scholar
  6. Zidan J, et al. Prevention of chemotherapy induced pancytopenia by special honey intake. 16th International Congress on Anti-Cancer Treatment. Paris, February 1st-4th, 2005. Poster, p: 349.
  7. White IW Jr. Honey. Adv Food Res 1978;24:288–374.
    Google Scholar
  8. Kukagawa K, Kunugi A, Kurechi T. Chemistry and implications of degradation of phenolic antioxidants in food antioxidant. Elsevier: New York, 1990.
    Google Scholar
  9. Rosenbalt G, Angonnet S, Goroshit A, Tabak M, Neeman I. Antioxidant properties of honey produced by bees fed with medical plant extracts. International Conference on: Bee Products: Properties, Applications and Aitherapy. Tel-Aviv, Israel, May 26–30, 1996.
  10. Bermond P. Biological effects of food antioxidants. In: Hudson BJF (ed) Food antioxidants. Elsevier Science Publishing Co. Inc: NY. 1990, pp: 193–251.
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Oncology Unit, Sieff Hospital, Safed, Israel
    Jamal Zidan, Lika Shetver, Amira Abzah, Sigalit Tamam & Moshe Stein
  2. Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
    Jamal Zidan
  3. Department of Clinical Oncology, Oldchurch Hospital, Romford, UK
    Anthony Gershuny
  4. Oncology Department, Rambam Medical Center, Haifa, Israel
    Anthony Gershuny
  5. Oncogenetic Unit, Sheba Medical Center, Tel-Hashomer, Israel
    Eitan Friedman

Authors

  1. Jamal Zidan
    You can also search for this author inPubMed Google Scholar
  2. Lika Shetver
    You can also search for this author inPubMed Google Scholar
  3. Anthony Gershuny
    You can also search for this author inPubMed Google Scholar
  4. Amira Abzah
    You can also search for this author inPubMed Google Scholar
  5. Sigalit Tamam
    You can also search for this author inPubMed Google Scholar
  6. Moshe Stein
    You can also search for this author inPubMed Google Scholar
  7. Eitan Friedman
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toJamal Zidan.

Rights and permissions

About this article

Cite this article

Zidan, J., Shetver, L., Gershuny, A. et al. Prevention of chemotherapy-induced neutropenia by special honey intake.Med Oncol 23, 549–552 (2006). https://doi.org/10.1385/MO:23:4:549

Download citation

Key Words